Menachem Shalom - 15 Jan 2026 Form 4 Insider Report for Nukkleus Inc. (NUKK)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Menachem Shalom
Issuer symbol: NUKK
Transactions as of: 15 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 20 Jan 2026, 19:57:12 UTC
Previous filing: 17 Nov 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Shalom Menachem	CEO, Director, 10%+ Owner	C/O NUKKLEUS INC., 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK	/s/ Menachem Shalom	20 Jan 2026	0002030245

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUKK	Common Stock$0.0001 par value per share	Other	$0	+1,992,010	+159%	$0.000000	3,242,010	16 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUKK	Common Stock Purchase Warrants	Other	$0	+5,018,359		$0.000000	5,018,359	15 Jan 2026	Common	5,018,359	$1.50	Direct	F1
transaction	NUKK	Call Option (to Purchase Common Stock and warrants)	Award		+1,752,593			1,752,593	13 Jan 2026	Common		$1.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the shares and warrants reported above.
F2	The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of Common Stock at a per share exercise price of $1.50. The right shall commence only after Esousa has sold a portion of said securities for gross proceeds equal to $3,000,000 (the "Satisfaction Date") and terminate upon the earlier of the parties agreeing in writing to its termination, when Esousa no longer holds the securities and 60 days after the Satisfaction Date.

Content

The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the shares and warrants reported above.

The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of Common Stock at a per share exercise price of $1.50. The right shall commence only after Esousa has sold a portion of said securities for gross proceeds equal to $3,000,000 (the "Satisfaction Date") and terminate upon the earlier of the parties agreeing in writing to its termination, when Esousa no longer holds the securities and 60 days after the Satisfaction Date.